TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Country Impact
5.3.3. Opportunity and Threat Analysis
6. SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE
6.1. Overview
6.2. Assisted Reproductive Technology (ART)
6.3. In-Vitro Fertilization
6.4. Artificial Insemination
6.5. Surrogacy
6.6. Others
7. SPAIN FERTILITY SERVICES MARKET, BY INFERTILITY
7.1. Overview
7.2. Male infertility
7.3. Female infertility
8. SPAIN FERTILITY SERVICES MARKET, BY END-USER
8.1. Overview
8.2. Fertility Clinics
8.3. Hospitals
8.4. Clinical Research Institutes
8.5. Surgical Centers
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Spain Fertility Services Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Spain Fertility Services Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. COMPANY PROFILES
10.1. THE COOPER COMPANIES INC.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Instituto Bernabeu
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Virtus Health
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. CooperSurgical, Inc
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. CARE Fertility
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. INVO Bioscience
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. MONASH IVF
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Fertility Focus Limited
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Carolinas Fertility Institute
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Apollo Hospitals Enterprise Ltd.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. MERCK KGAA
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. VITROLIFE
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. Monash IVF
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Products Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 SPAIN: FERTILITY SERVICES MARKET, BY PROCEDURE, 2018-2032 (USD BILLION)
TABLE 2 SPAIN: FERTILITY SERVICES MARKET, BY INFERTILITY, 2018-2032 (USD BILLION)
TABLE 3 SPAIN: FERTILITY SERVICES MARKET, BY END-USER, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE SPAIN FERTILITY SERVICES MARKET
FIGURE 3 MARKET DYNAMICS FOR THE SPAIN FERTILITY SERVICES MARKET
FIGURE 4 SPAIN: FERTILITY SERVICES MARKET, SHARE (%), BY COUNTRY, 2022
FIGURE 5 SPAIN FERTILITY SERVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 6 THE COOPER COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 7 THE COOPER COMPANIES INC.: SWOT ANALYSIS
FIGURE 8 INSTITUTO BERNABEU: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 9 INSTITUTO BERNABEU: SWOT ANALYSIS
FIGURE 10 VIRTUS HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 11 VIRTUS HEALTH: SWOT ANALYSIS
FIGURE 12 COOPERSURGICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 COOPERSURGICAL, INC.: SWOT ANALYSIS
FIGURE 14 CARE FERTILITY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 CARE FERTILITY: SWOT ANALYSIS
FIGURE 16 INVO BIOSCIENCE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 INVO BIOSCIENCE: SWOT ANALYSIS
FIGURE 18 MONASH IVF: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 MONASH IVF: SWOT ANALYSIS
FIGURE 20 FERTILITY FOCUS LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 FERTILITY FOCUS LIMITED: SWOT ANALYSIS
FIGURE 22 CAROLINAS FERTILITY INSTITUTE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CAROLINAS FERTILITY INSTITUTE: SWOT ANALYSIS
FIGURE 24 APOLLO HOSPITALS ENTERPRISE LTD..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 APOLLO HOSPITALS ENTERPRISE LTD..: SWOT ANALYSIS
FIGURE 26 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MERCK KGAA: SWOT ANALYSIS
FIGURE 28 VITROLIFE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 VITROLIFE: SWOT ANALYSIS
FIGURE 30 MONASH IVF: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MONASH IVF: SWOT ANALYSIS